David Piacquad - Net Worth and Insider Trading
David Piacquad Net Worth
The estimated net worth of David Piacquad is at least $11 Million dollars as of 2024-04-24. David Piacquad is the SVP, Business Development of Amgen Inc and owns about 39,700 shares of Amgen Inc (AMGN) stock worth over $11 Million. Details can be seen in David Piacquad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Piacquad has not made any transactions after 2020-02-06 and currently still holds the listed stock(s).
Transaction Summary of David Piacquad
David Piacquad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Piacquad owns 2 companies in total, including Amgen Inc () , and Neumora Therapeutics Inc () .
Click here to see the complete history of David Piacquad’s form 4 insider trades.
Insider Ownership Summary of David Piacquad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Amgen Inc | 2020-02-06 | SVP & Business Development | |
| Neumora Therapeutics Inc | 2023-09-14 | director |
David Piacquad Latest Holdings Summary
David Piacquad currently owns a total of 1 stock. David Piacquad owns 39,700 shares of Amgen Inc (AMGN) as of February 6, 2020, with a value of $11 Million.
David Piacquad Form 4 Trading Tracker
According to the SEC Form 4 filings, David Piacquad has made a total of 1 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amgen Inc is the sale of 9,264 shares on February 6, 2020, which brought David Piacquad around $2 Million.
Insider Trading History of David Piacquad
- 1
David Piacquad Trading Performance
David Piacquad Ownership Network
Ownership Network List of David Piacquad
Ownership Network Relation of David Piacquad
David Piacquad Owned Company Details
What does Amgen Inc do?
Who are the key executives at Amgen Inc?
David Piacquad is the SVP & Business Development of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .
Amgen Inc () Insider Trades Summary
Over the past 18 months, David Piacquad made no insider transaction in Amgen Inc (). Other recent insider transactions involving Amgen Inc () include a net sale of 2,641 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .
In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,586 shares of Amgen Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,586 shares.
Amgen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Amgen Inc Insider Transactions
David Piacquad Mailing Address
Above is the net worth, insider trading, and ownership report for David Piacquad. You might contact David Piacquad via mailing address: One Amgen Center Drive, Thousand Oaks Ca 91320-1799.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
